News

Stay updated and learn about the topic of personalized medicine. Comment and share freely. In addition, let us know if you wish us to dig deeper into any new subject.
CurifyLabs and the Pharmacy Podcast Network - Episode 2

Featured Post

CurifyLabs and the Pharmacy Podcast Network - Episode 2

Pharmacy Podcast Network

Part One: Trust, Technology & the Future of Compounding

 

What if the future of personalized medicine wasn't just about developing new treatments, but transforming how pharmacies prepare medications for individual patients?

In this episode of the CurifyLabs Podcast Series, we sit down with founders Charlotta Topelius and Niklas Sandler Topelius to explore the inspiration, challenges, and mission behind CurifyLabs. From recognizing limitations in traditional pharmaceutical compounding to envisioning a more standardized, efficient, and scalable approach, the founders share how their commitment to innovation evolved into a mission to make personalized medicines more accessible to patients and the pharmacists who serve them.

The conversation goes beyond 3D printing to explore why CurifyLabs developed an integrated compounding ecosystem rather than a standalone device. By bringing together validated formulations, specialized excipient bases, automated mixing and dispensing, quality-control capabilities, and digital batch documentation, CurifyLabs aims to help pharmacies modernize compounding while preserving the essential expertise and clinical judgment of pharmacists. Charlotta and Niklas also share their perspectives on the next generation of personalized medicine, the importance of pharmacist-driven innovation, and their vision for a future where technology helps make individualized treatment more practical, consistent, and accessible.

Key Topics Discussed

  • The origin story and entrepreneurial vision behind CurifyLabs.

  • Why personalized medicine needs new approaches to pharmaceutical compounding.

  • The mission to make individualized medications more accessible.

  • Why CurifyLabs developed a complete compounding ecosystem instead of just a pharmaceutical printer.

  • How automation, validated formulations, and standardized workflows can support quality and consistency.

  • The evolving role of pharmacists in technology-enabled personalized medicine.

  • How pharmacist feedback and research influence future innovation.

  • The founders' vision for the next five years of pharmaceutical compounding.

The Big Takeaway: CurifyLabs is working toward a future in which personalized medicine is not the exception, but an increasingly practical part of everyday pharmacy care. Its mission goes beyond the technology itself: empowering pharmacists with tools and processes that support individualized treatment while keeping patient needs at the center of innovation.Listen to “Trust, Technology & the Future of Compounding” to hear the full conversation.

PRESS RELEASE: Pharmacies' medicine compounding capability is part of security of supply — in Finland, it is thinning out

The decline of pharmacies' medication production capacity in Finland threatens healthcare resilience, prompting calls for a decentralized network of capable pharmacies.
Press Releases
Read More

LEHDISTÖTIEDOTE: Apteekkien lääkkeiden valmistuskyky on osa huoltovarmuutta — Suomessa se on ohentumassa

The decline of pharmacies' medication production capacity in Finland threatens healthcare resilience, prompting calls for a decentralized network of capable pharmacies.
Press Releases
Read More

CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine

CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
Press Releases News
Read More

NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology

https://press.apl.se/posts/pressreleases/forsta-leveransen-av-extemporelakemedel-tillv
Press Releases Use cases
Read More

Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets

CurifyLabs introduces CuraBlend®Vet, a 3D-printed, flavored gel tablet for pets, improving adherence and simplifying medication administration with personalized dosages.
Press Releases
Read More

Press Release: New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers

Press release CurifyLabs New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers.
Press Releases
Read More

Press Release: CurifyLabs Launches Next-Generation Compounding Software to Advance Personalized Medicine

CurifyLabs launches advanced compounding software, enhancing 3D printing technology for hospitals and pharmacies to deliver faster, safer, and more personalized medication solutions.
Press Releases News
Read More

CurifyLabs Leads €5.6M EU-Funded RoboPharma Project and raised €6.7M to Modernise Personalised Medicine!

CurifyLabs raises €6.7M and leads a €5.6M EU-funded RoboPharma project to revolutionize the manufacturing of personalized medicine with automation and AI.
Press Releases
Read More

Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments

Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments
Press Releases
Read More

CurifyLabs’ Technology Validated in European-Wide Study

CurifyLabs peer reviewed article, Delpech Paris, Charite, Helios, Lausanne University Hospital, Mainz University Hospital
Press Releases News
Read More